Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy.
Ziemssen
F
F
Voelker
M
M
Inhoffen
W
W
Bartz-Schmidt
K U
KU
Gelisken
F
F
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003131:Combined Modality Therapy / Q000379:methods; D018324:Hemangioma, Capillary / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D010778:Photochemotherapy; D019572:Retinal Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D014792:Visual Acuity
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab